Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 26;11(15):4327.
doi: 10.3390/jcm11154327.

Impact of Hidradenitis Suppurativa Surgical Treatment on Health-Related Life Quality

Affiliations

Impact of Hidradenitis Suppurativa Surgical Treatment on Health-Related Life Quality

Marcin Gierek et al. J Clin Med. .

Abstract

(1) Background: Hidradenitis suppurativa is a disease that affects the intimacy of patients. This disease reduces the quality of life and functioning of patients in everyday life. The surgical treatment of HS is one of the treatments for HS that can improve the quality of life. (2) Methods: The main goal of this study was to assess quality of life before the surgical treatment and after the surgical treatment of HS at Center for Burn Treatment in Siemianowice Śląskie, Poland, using the EQ-5D-5L survey before the operation and at follow-up (6 months after). (3) Results: The average quality of life measured with the EQ-5D-5L survey before therapy was 39.3 ± 20.1 (min., 0; max., 60; most frequent value, 50), whereas after surgical treatment, the mean quality of life was 89.5 ± 12.5 (min., 50; max., 100; most frequent value, 100). The average increase in the quality of life was 50.2 ± 19.5 (min., 30; max., 100; most frequent value, 30), and it was statistically significant (p < 0.001).

Keywords: hidradenitis suppurativa; quality of life; surgical treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Types of surgical reconstructive techniques used in the surgical treatment of HS. (A) Flap reconstruction: left—HS of right axilla (A-1); center—wide excision (A-2); right—rotatory-flap reconstruction (A-3). (B) Flap reconstruction: left—HS of left axilla (B-1); center—wide excision (B-2); right—bilobed reconstruction (B-3). (C) Split-thickness skin graft: left—HS of left axilla and chest (C-1); center—wide excision and split-thickness skin graft (C-2); right—reconstruction with split-thickness skin graft (C-3). (D) Mixed technique (Flap + STSG): left—HS of right axilla (D-1); center—wide excision (D-2); right—reconstruction with a rotatory flap and split-thickness skin graft (D-3).

References

    1. Zouboulis C.C., Desai N., Emtestam L., Hunger R.E., Ioannides D., Juhász I., Lapins J., Matusiak L., Prens E.P., Revuz J., et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J. Eur. Acad. Dermatol. Venereol. JEADV. 2015;29:619–644. doi: 10.1111/jdv.12966. - DOI - PubMed
    1. Marasca C., Tranchini P., Marino V., Annunziata M.C., Napolitano M., Fattore D., Fabbrocini G. The pharmacology of antibiotic therapy in hidradenitis suppurativa. Expert Rev Clin Pharmacol. 2020;13:521–530. doi: 10.1080/17512433.2020.1762571. - DOI - PubMed
    1. Scala E., Cacciapuoti S., Garzorz-Stark N., Megna M., Marasca C., Seiringer P., Volz T., Eyerich K., Fabbrocini G. Hidradenitis Suppurativa: Where We Are and Where We Are Going. Cells. 2021;10:2094. doi: 10.3390/cells10082094. - DOI - PMC - PubMed
    1. Goldburg S.R., Strober B.E., Payette M.J. Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis. J. Am. Acad. Dermatol. 2020;82:1045–1058. doi: 10.1016/j.jaad.2019.08.090. - DOI - PubMed
    1. Nguyen T.V., Damiani G., Orenstein L., Hamzavi I., Jemec G.B. Hidradenitis suppurativa: An update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life. J. Eur. Acad. Dermatol. Venereol. JEADV. 2021;35:50–61. doi: 10.1111/jdv.16677. - DOI - PubMed

LinkOut - more resources